(CIDRAP News) – Flu activity in the United States and Europe showed more signs of picking up last week, with labs in both parts of the world finding higher percentages of positives in tests of respiratory samples, according to new surveillance reports today.
(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the first quadrivalent influenza vaccine, an inhaled live attenuated influenza vaccine developed by MedImmune and modeled after its FluMist product.
The vaccine includes a second influenza B strain, which is designed to broaden protection against circulating strains. MedImmune plans to have the quadrivalent vaccine ready for the 2013-14 flu season.
(CIDRAP News) – Flu activity in the United States continued its late-season rise last week, with more respiratory specimens testing positive and more states reporting widespread activity, but flu-like illness stayed relatively low overall, the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) – In a new twist in the ongoing controversy over publication of two studies involving H5N1 viruses with increased transmissibility, there are indications that the Dutch government may consider using export regulations to prevent full publication of the study by Ron Fouchier, PhD, and colleagues.